A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
Public ClinicalTrials.gov record NCT02110901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This research study is designed to assess the safety and effectiveness of an experimental drug called PRT-201 in patients both receiving or expecting to receive dialysis who have chronic kidney disease and who are undergoing surgery to create a new access point to their bloodstream for hemodialysis. PRT-201 is a protein that has been shown in previous research studies to help keep vessels patent when applied to the outside surface of the blood vessels (arteries and veins) in patients who undergo surgery to create an arteriovenous fistula (AVF). The purpose of this study is to determine whether PRT-201 when applied to a limited segment of your blood vessel (about 2 inches) immediately after surgery is safe and improves the patency of your AVF.
Study identification
- NCT ID
- NCT02110901
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 349 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2014 (Actual)
- Primary completion
- Dec 2016 (Actual)
- Completion
- Dec 2018 (Actual)
- Last update posted
- Jul 9, 2019
2014 – 2018
United States locations
- U.S. sites
- 35
- U.S. states
- 18
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| AKDHC Medical Research Services , LLC | Phoenix | Arizona | 85012 | — |
| AKDHC Medical Research Services, LLc | Tucson | Arizona | 85719 | — |
| Alliance Research Center | Laguna Hills | California | 92653 | — |
| VA Medical Center Long Beach | Long Beach | California | 90822 | — |
| Keck University Hospital at USC | Los Angeles | California | 90033 | — |
| Kaiser Permanente Medical Center | San Diego | California | 92120 | — |
| California Institute of Renal Research | San Diego | California | 92123 | — |
| UCSF Division of Vascular & Endovascular Surgery | San Francisco | California | 94143 | — |
| Rush Medical Center | Chicago | Illinois | 60612 | — |
| Renal Care Associates | Peoria | Illinois | 61603 | — |
| Lutheran Hospital Network of Indiana | Fort Wayne | Indiana | 46804 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| Louisiana State University Health Sciences Center | Shreveport | Louisiana | 71130 | — |
| Maine Medical Center | Portland | Maine | 04102 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| University of Maryland Shore Medical Center at Easton | Easton | Maryland | 21601 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02482 | — |
| University of Massachusetts Medical Center | Worcester | Massachusetts | 01655 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| W.G. Hefner VA Medical Center | Salisbury | North Carolina | 28144 | — |
| Wake Forest | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45267 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| The University of Oklahoma College of Medicine | Tulsa | Oklahoma | 74104 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | — |
| VA Pittsburg Healthcare System | Pittsburgh | Pennsylvania | 15240 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
| Lake Washington Vascular Center | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02110901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2019 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02110901 live on ClinicalTrials.gov.